<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615272</url>
  </required_header>
  <id_info>
    <org_study_id>0733</org_study_id>
    <nct_id>NCT05615272</nct_id>
  </id_info>
  <brief_title>Treatment of Alveolar Osteitis: Traditional or Regenerative?</brief_title>
  <official_title>A Clinical Investigation of the Efficacy of Platelet Rich Fibrin (Bio-PRF) Compared to Alveogyl in the Treatment of Alveolar Osteitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Dublin, Trinity College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alveolar osteitis, commonly referred to as dry socket, is a common painful postoperative&#xD;
      complication following tooth extraction. It is defined as pain in and around an extraction&#xD;
      socket which increases at any time between one and three days following extraction,&#xD;
      accompanied by partial or total loss of the blood clot from the socket, with or without&#xD;
      halitosis (Blum, 2002).&#xD;
&#xD;
      The incidence of the complication varies from 1-5% for routine extractions up to&#xD;
      approximately 30% for third molar extractions. There are a variety of factors that contribute&#xD;
      to the incidence of dry socket including tissue trauma, smoking in the early postoperative&#xD;
      period and the oral contraceptive pill. Although it is a self- limiting condition, symptoms&#xD;
      can be very debilitating for patients and therefore following diagnosis, immediate treatment&#xD;
      should be provided to expedite resolution and to their improve quality of life during the&#xD;
      healing period. Treatment options for dry socket vary from rinsing of the socket, regular&#xD;
      analgesia and sometimes placement of an obtundent, sedative dressing such as Alveogyl or a&#xD;
      zinc oxide eugenol alternative.&#xD;
&#xD;
      This study will aim to compare two treatments for patients who present with alveolar osteitis&#xD;
      (dry socket) to Dublin Dental University Hospital after tooth extraction. Following&#xD;
      randomisation, one of two treatment modalities will be used, either a experimental treatment&#xD;
      (Bio-PRF) or a positive control (Alveogyl).&#xD;
&#xD;
      The results of this study will enable us to learn more about the efficacy of these treatment&#xD;
      options for dry socket and how they affect patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in postoperative pain levels: Day 0 to Day 3</measure>
    <time_frame>Day 3 following intervention</time_frame>
    <description>Pain will be measured using a pain diary with VAS scale (0-100) at baseline and Day 3. The changes in patient pain levels from baseline will be compared to Day 3 for each group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in postoperative pain levels: Day 0 to Day 7</measure>
    <time_frame>Day 7 following intervention</time_frame>
    <description>Pain will be measured using a pain diary with VAS scale (0-100) at baseline and Day 7. The changes in patient pain levels from baseline will be compared to Day 7 for each group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing</measure>
    <time_frame>Day 7 following intervention</time_frame>
    <description>Healing will be measured clinically by second blinded assessor using a modified version of the Landry Healing Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Measurements (QoL)</measure>
    <time_frame>Day 7 following intervention</time_frame>
    <description>The patient's QoL will be assessed using a questionnaire modified from the postoperative symptom severity scale (PoSSe) ranging from 1-5, where 1 correlates to no impact on their quality of life and 5 signifies major impact on their quality of life. Higher scores will mean worse outcome if by Day 7, the patient's QoL scores remain high.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Alveolar Osteitis</condition>
  <condition>Dry Socket</condition>
  <condition>Pain</condition>
  <condition>Healing</condition>
  <condition>Tooth Extraction</condition>
  <arm_group>
    <arm_group_label>Bio-PRF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a blood-derived platelet rich concentrate from the patient's whole blood sample. The patient typically donates two 9ml (1.5 tablespoons) vials of blood that is then spun in a centrifuge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alveogyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alveogyl is an intraalveolar sedative, obtundent dressing, which contains the active ingredient eugenol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bio-PRF</intervention_name>
    <description>Intervention group</description>
    <arm_group_label>Bio-PRF</arm_group_label>
    <other_name>Blood Sample</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alveogyl</intervention_name>
    <description>Control group</description>
    <arm_group_label>Alveogyl</arm_group_label>
    <other_name>Intraalveolar Dressing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and females adults at least 18 years old&#xD;
&#xD;
          -  A diagnosis of alveolar osteitis following tooth extraction based on patients having&#xD;
             both pain and exposed bone&#xD;
&#xD;
          -  Good command of the English language&#xD;
&#xD;
          -  Willingness to keep a diary of symptoms and travel for the review appointment on day 7&#xD;
             following intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Current or previous bisphosphonate used or history of radiotherapy to the jaws&#xD;
&#xD;
          -  Allergy or intolerance to study materials&#xD;
&#xD;
          -  Lack of capacity to consent to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Dr Beattie</last_name>
    <role>Study Director</role>
    <affiliation>Specialist Oral Surgeon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Ed Mr O'Connell</last_name>
    <role>Study Director</role>
    <affiliation>Consultant Maxillofacial Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maeve Cooney</last_name>
    <phone>+353872529024</phone>
    <email>maeve.cooney@dental.tcd.ie</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dublin Dental University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maeve Cooney</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 24, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Dublin, Trinity College</investigator_affiliation>
    <investigator_full_name>Maeve Cooney</investigator_full_name>
    <investigator_title>Postgraduate Student in Oral Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteitis</mesh_term>
    <mesh_term>Dry Socket</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

